Zobrazeno 1 - 10
of 23 843
pro vyhledávání: '"Biologics"'
Autor:
Ledford DK, Carr WW, Moore WC, Lugogo NL, Mohan A, Chipps B, Mackie AR, Lindsley AW, Spahn J, Ambrose CS
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 17, Pp 977-982 (2024)
Dennis K Ledford,1 Warner W Carr,2 Wendy C Moore,3 Njira L Lugogo,4 Arjun Mohan,4 Bradley Chipps,5 Alexander R Mackie,6 Andrew W Lindsley,7 Joseph Spahn,6 Christopher S Ambrose8 1Division of Allergy and Immunology, University of South Florida, Tampa,
Externí odkaz:
https://doaj.org/article/5882d21ddd0744a68b9ef6199db8b80c
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 2093-2105 (2024)
Sungwon Jung,1 David Suh,2 Seung-Mi Lee3 1College of Pharmacy, Sookmyung Women’s University, Seoul, 04310, Republic of Korea; 2School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA; 3College of Pharmacy, Daegu Catholic Universi
Externí odkaz:
https://doaj.org/article/9cbda80994a7409ebef8bdb7f0710a7e
Autor:
Matthias Augustin, Alice B. Gottlieb, Mark Lebwohl, Andreas Pinter, Richard B. Warren, Luis Puig, Rhys Warham, Jérémy Lambert, Susanne Wiegratz, Balint Szilagyi, Andrew Blauvelt
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2841-2857 (2024)
Abstract Introduction With newer biologics, the achievement of complete skin clearance has become an attainable treatment goal for patients with plaque psoriasis. We evaluate how improvements in Psoriasis Area and Severity Index (PASI) responses, par
Externí odkaz:
https://doaj.org/article/87932ef0b7d34aacbbdc912e39e468f6
Autor:
Andrew Blauvelt, Robert R. McLean, Silky W. Beaty, Adam P. Sima, Robert Low, Jeffrey L. Stark, Laura McClung, Jerry Bagel
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2787-2804 (2024)
Abstract Introduction Due to variable psoriasis symptoms, disease progression, and individual responses to therapy, patients may start, stop, or switch biologic therapies. Real-world data on the associated disease burden of patients with psoriasis wh
Externí odkaz:
https://doaj.org/article/ede9b9cf4a944a92a0a00b008cb24666
Autor:
Chia-Yu Chu, Ramesh Bhat Marne, Christina Man-Tung Cheung, Le Ngoc Diep, Nopadon Noppakun, Endi Novianto, Maria Lourdes H. Palmero, Yong-Kwang Tay, Azizan Noor Zalmy
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2669-2691 (2024)
Abstract Introduction Rapid progress made in the management of atopic dermatitis (AD) in recent years and the differences in patient journey between Asian and non-Asian populations call for a review of current atopic dermatitis landscape in Asia. Met
Externí odkaz:
https://doaj.org/article/ea49b7cf2ff94ed6b4a6c6b10a8cfdb8
Autor:
Philip J. Mease, Andrew Blauvelt, Adam P. Sima, Silky W. Beaty, Robert Low, Braulio Gomez, Marie Gurrola, Mark G. Lebwohl
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2805-2825 (2024)
Abstract Introduction Patients with psoriasis (PSO) and psoriatic arthritis (PsA) may frequently switch biologic therapies over the course of treatment because of symptom variability and individual responses. Real-world studies analyzing patient char
Externí odkaz:
https://doaj.org/article/731ad32209df4df48709691147b30c59
Autor:
Noa Krugliak Cleveland, Sabyasachi Ghosh, Benjamin Chastek, Tim Bancroft, Ninfa Candela, Tao Fan, Kandavadivu Umashankar, David T. Rubin
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Patients with inflammatory bowel disease (IBD) are at risk of developing dysplasia and, subsequently, colorectal cancer (CRC) owing to chronic inflammation. Patients may also experience other severe disease complications, such as
Externí odkaz:
https://doaj.org/article/15633947d5b943d39a018a5fb77c8c65
Autor:
Priyanga Ranasinghe, Chiranthi Liyanage, Nirmala Sirisena, Sandamini Liyanage, C. D. Nelanka Priyadarshani, D. P. Bhagya Hendalage, Vajira H. W. Dissanayake
Publikováno v:
Human Genomics, Vol 18, Iss 1, Pp 1-13 (2024)
Abstract Background Immunomodulators are important for management of autoimmune diseases and hematological malignancies. Significant inter-individual variation in drug response/reactions exists due to genetic polymorphisms. We describe frequency of i
Externí odkaz:
https://doaj.org/article/1837d50994954a04a2fec128baa4708e
Autor:
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, Fabiola Atzeni, Angelo Semeraro, Salvatore D’Angelo, Carlo Selmi, Augusta Ortolan, Antonio Marchesoni, Maria Manara, Michele Maria Luchetti Gentiloni, Leonardo Santo, Carlo Salvarani, Alberto Cauli, Maurizio Rossini, Giorgio Amato, Giacomo Cozzi, Laura Scagnellato, Mario Ferraioli, Antonio Carriero, Elena Fracassi, Francesco Giorgio, Andrea Doria, Rosario Foti, Antonio Carletto, on behalf Spondyloarthritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-16 (2024)
Abstract Objectives to evaluate over a 48-month follow-up period the: 1) long-term effectiveness and safety; 2) drug retention rate (DRR); 3) impact of comorbidities and bDMARDs line on MDA and DAPSA remission/low disease activity (LDA) of secukinuma
Externí odkaz:
https://doaj.org/article/3ca00c18f62e4f93a4c5e5ec400982f1
Autor:
Annamaria Bosi, Carlo Lombardi, Cristiano Caruso, Marcello Cottini, Ilaria Baglivo, Stefania Colantuono, Francesco Menzella
Publikováno v:
Drugs in Context, Vol 13, Pp 1-15 (2024)
Over the last two decades, we have witnessed great advancements in our understanding of the immunological pathways of asthma, leading to the development of targeted therapies, such as biologic drugs, that have radically and definitively changed the c
Externí odkaz:
https://doaj.org/article/2997b350b664461bb87cda31bc3c9c38